10 Best Medical AI Companies

4. Moderna, Inc. (NASDAQ:MRNA)

Number of Hedge Fund Holders: 39

Market Capitalization: $31.7 billion

Moderna, Inc. (NASDAQ:MRNA) is a biotech company based in Cambridge, Massachusetts. It develops messenger RNA therapeutics and vaccines to treat infectious diseases, rare diseases, and more. Moderna, Inc. (NASDAQ:MRNA) initially gained fame and investments for its active role in providing COVID-19 vaccines during the pandemic, but it continues to retain investor attention even today for several reasons.

One of these reasons is that Moderna, Inc. (NASDAQ:MRNA) has several late-stage candidates in the drug development pipeline. Additionally, the company has made AI in medicine a priority. AI is being used by Moderna, Inc. (NASDAQ:MRNA) in vaccine development to speed up key steps for researchers. In 2024, the company also announced a partnership with International Business Machines to use its technology to supercharge its own research.

One example of the use of IBM tech in Moderna, Inc.’s operations (NASDAQ:MRNA) is the predictive role of IBM’s foundation model, MolFormer, is playing for Moderna, Inc. (NASDAQ:MRNA) to predict the properties of molecules. Through this, the biotech company will be able to develop better mRNA medicines more quickly. As a result, several investors are interested in Moderna, Inc. (NASDAQ:MRNA) and consider it to be one of the top medical AI stocks to buy today.

In total, 39 hedge funds were long Moderna, Inc. (NASDAQ:MRNA) in the second quarter, with a total stake value of $1.3 billion.